Seymour, M.T., Thompson, L.C., Wasan, H.S., et al. (2011) Chemotherapy Options in Elderly and Frail Patients with Metastatic Colorectal Cancer (MRC FOCUS2): An Open-Label, Randomised Factorial Trial. The Lancet, 377, 1749-1759.
https://doi.org/10.1016/S0140-6736(11)60399-1

has been cited by the following article:

• TITLE: A Sustained Complete Response in an Elderly Patient with Metastatic Colorectal Adenocarcinoma—A Clinical Case

  AUTHORS: Maria Leitão, Isabel Vilas-Boas, Manuela Machado

  KEYWORDS: Elderly, Chemotherapy, Cancer, Colorectal

  JOURNAL NAME: Journal of Cancer Therapy, Vol.11 No.6, May 29, 2020

  ABSTRACT: Background: The increasing life expectancy of people worldwide will signify that oncologists everywhere will be faced with many difficult decisions regarding treatment options in the elderly population with cancer. These patients carry specific challenges that should be discussed. Aim: To report the clinical case of an elderly patient with a metastatic colorectal cancer with a sustained complete response and reflect on the particularities on this special population. Clinical case: In 2009, an 80-year-old man presents with colorectal cancer, undergoes surgery and intraoperatively a peritoneal implant is resected. He is deemed fit for chemotherapy and is treated with 8 cycles of capecitabine. After a 10-year follow-up, he remains with no evidence of disease. Conclusion: Chronological age is insufficient to establish a treatment plan; oncologists must evaluate the patient multidimensionally and develop personalized options for the therapy and follow-up of older individuals.